Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Combining laser capture microdissection and proteomics reveals an active translation machinery controlling invadosome formation.

Ezzoukhry Z, Henriet E, Cordelières FP, Dupuy JW, Maître M, Gay N, Di-Tommaso S, Mercier L, Goetz JG, Peter M, Bard F, Moreau V, Raymond AA, Saltel F.

Nat Commun. 2018 May 23;9(1):2031. doi: 10.1038/s41467-018-04461-9.

2.

2D and 3D Matrices to Study Linear Invadosome Formation and Activity.

Di Martino J, Henriet E, Ezzoukhry Z, Mondal C, Bravo-Cordero JJ, Moreau V, Saltel F.

J Vis Exp. 2017 Jun 2;(124). doi: 10.3791/54911.

3.

Unr defines a novel class of nucleoplasmic reticulum involved in mRNA translation.

Saltel F, Giese A, Azzi L, Elatmani H, Costet P, Ezzoukhry Z, Dugot-Senant N, Miquerol L, Boussadia O, Wodrich H, Dubus P, Jacquemin-Sablon H.

J Cell Sci. 2017 May 15;130(10):1796-1808. doi: 10.1242/jcs.198697. Epub 2017 Apr 6.

4.

TGF-β1 promotes linear invadosome formation in hepatocellular carcinoma cells, through DDR1 up-regulation and collagen I cross-linking.

Ezzoukhry Z, Henriet E, Piquet L, Boyé K, Bioulac-Sage P, Balabaud C, Couchy G, Zucman-Rossi J, Moreau V, Saltel F.

Eur J Cell Biol. 2016 Nov;95(11):503-512. doi: 10.1016/j.ejcb.2016.09.003. Epub 2016 Oct 4.

PMID:
27720259
5.

The microenvironment controls invadosome plasticity.

Di Martino J, Henriet E, Ezzoukhry Z, Goetz JG, Moreau V, Saltel F.

J Cell Sci. 2016 May 1;129(9):1759-68. doi: 10.1242/jcs.182329. Epub 2016 Mar 30. Review.

6.

[Ferroptosis, a new form of cell death relevant to the medical treatment of cancer].

Lachaier E, Louandre C, Ezzoukhry Z, Godin C, Mazière JC, Chauffert B, Galmiche A.

Med Sci (Paris). 2014 Aug-Sep;30(8-9):779-83. doi: 10.1051/medsci/20143008016. Epub 2014 Sep 1. Review. French.

7.

Heterogeneous sensitivity of hepatocellular carcinoma to sorafenib revealed by the short-term culture of tumor fragments.

Godin C, Dupont S, Ezzoukhry Z, Louandre C, Chatelain D, Henaut L, Sabbagh C, Regimbeau JM, Maziere JC, Barbare JC, Chauffert B, Galmiche A.

Anticancer Res. 2013 Apr;33(4):1415-20.

PMID:
23564781
8.

Iron-dependent cell death of hepatocellular carcinoma cells exposed to sorafenib.

Louandre C, Ezzoukhry Z, Godin C, Barbare JC, Mazière JC, Chauffert B, Galmiche A.

Int J Cancer. 2013 Oct 1;133(7):1732-42. doi: 10.1002/ijc.28159. Epub 2013 Apr 8.

9.

EGFR activation is a potential determinant of primary resistance of hepatocellular carcinoma cells to sorafenib.

Ezzoukhry Z, Louandre C, Trécherel E, Godin C, Chauffert B, Dupont S, Diouf M, Barbare JC, Mazière JC, Galmiche A.

Int J Cancer. 2012 Dec 15;131(12):2961-9. doi: 10.1002/ijc.27604. Epub 2012 Apr 30.

10.

The Bcl-2 homology domain 3 (BH3) mimetic ABT-737 reveals the dynamic regulation of bad, a proapoptotic protein of the Bcl-2 family, by Bcl-xL.

Ezzoukhry Z, Louandre C, François C, Saidak Z, Godin C, Mazière JC, Galmiche A.

Mol Pharmacol. 2011 Jun;79(6):997-1004. doi: 10.1124/mol.110.070565. Epub 2011 Mar 10.

PMID:
21393385
11.

[Regulation of cell survival by RAF kinases].

Galmiche A, Ezzoukhry Z.

Med Sci (Paris). 2010 Aug-Sep;26(8-9):729-33. doi: 10.1051/medsci/2010268-9729. Review. French.

12.

BAD, a proapoptotic member of the BCL2 family, is a potential therapeutic target in hepatocellular carcinoma.

Galmiche A, Ezzoukhry Z, François C, Louandre C, Sabbagh C, Nguyen-Khac E, Descamps V, Trouillet N, Godin C, Regimbeau JM, Joly JP, Barbare JC, Duverlie G, Mazière JC, Chatelain D.

Mol Cancer Res. 2010 Aug;8(8):1116-25. doi: 10.1158/1541-7786.MCR-10-0029. Epub 2010 Jul 20.

Supplemental Content

Loading ...
Support Center